NAD+ IV Therapy Side Effects: Safety, Risks & What to Expect

NAD+ IV therapy can cause temporary infusion-related side effects, particularly when the infusion is administered faster than an individual comfortably tolerates. Reported experiences include nausea, abdominal cramping, diarrhea, vomiting, flushing, headache, throat discomfort, chest pressure, increased heart rate, fatigue, and lightheadedness. Human evidence on long-term NAD+ IV safety and effectiveness remains limited.

A 2026 real-world pilot study comparing intravenous NAD+ with intravenous nicotinamide riboside found noticeably poorer tolerability in the NAD+ group. Participants receiving NAD+ reported gastrointestinal symptoms, increased heart rate, throat discomfort, and chest pressure during infusion. The study was small, so it should not be used to predict what every patient will experience, but it reinforces the importance of careful clinical supervision and infusion tolerance.

At Drip Lounge, the goal of an NAD+ IV session is not to finish the infusion as quickly as possible. Treatment should be delivered with attention to individual tolerance, health history, current symptoms, and comfort during the appointment.

If you are new to NAD+, start with our guide to what NAD+ IV therapy is and how it works.

Written by: Drip Lounge Editorial Team
Medically reviewed by: Megan Nickerson, DNP · Last medically reviewed: August 2026
Last updated: August 2026

Medical disclaimer: This article provides general educational information and does not replace individualized medical advice. NAD+ IV therapy is not an FDA-approved treatment for preventing, diagnosing, treating, or curing disease. Do not use this article to self-administer NAD+, select a dose, change an infusion rate, or treat a medical condition.

NAD+ IV Side Effects at a Glance

The 2026 retrospective pilot study was very small—only six participants received NAD+—but all six reported moderate-to-severe abdominal cramping, diarrhea, nausea, vomiting, increased heart rate, throat discomfort, congestion, and chest pressure during their infusions. Symptoms resolved after the infusion ended, and discomfort led participants to slow the infusion.

That does not mean every NAD+ IV patient will experience those symptoms. It does mean that NAD+ IV should not be marketed as though it is always a quick, symptom-free hydration drip.

Important: Chest pain, breathing difficulty, fainting, facial or throat swelling, severe vomiting, severe abdominal pain, or rapidly worsening symptoms should not be dismissed as a “normal NAD reaction.” Seek appropriate medical evaluation.

What Is NAD+ IV Therapy?

Nicotinamide adenine dinucleotide, or NAD+, is a naturally occurring coenzyme found in human cells. It participates in important biological processes involving:

• cellular energy metabolism;
• redox reactions;
• mitochondrial function;
• DNA-related cellular processes;
• and cell signaling.

Interest in NAD+ has increased because NAD biology changes with age and is involved in many metabolic pathways.

But there is an important distinction between NAD+ being essential to normal cellular biology and intravenous NAD+ having proven clinical benefits for a particular health condition. Those statements are not equivalent.

If you want a deeper introduction before focusing on safety, read What Is NAD+ IV Therapy?.

Why Can NAD+ IV Cause Side Effects?

There is no single explanation for every symptom experienced during an NAD+ infusion. However, one of the most important practical factors appears to be infusion tolerance and pace.

Infusion Pace Matters

NAD+ IV is not necessarily experienced like a standard saline hydration infusion. Some people may tolerate the infusion comfortably, while others report discomfort that limits how quickly the infusion can be delivered.

In the 2026 pilot study, NAD+ participants required an average infusion time of approximately 97 minutes, compared with 37 minutes for the nicotinamide-riboside IV group. The longer duration was related to infusion-related symptoms and participant-directed slowing of the NAD+ infusion.

The study does not establish an ideal infusion duration for every patient. It does, however, support an important principle: faster is not automatically better with NAD+ IV. The objective should be an appropriately supervised infusion that the individual can tolerate—not completing the bag as fast as possible.

More NAD+ Is Not Automatically Better

Higher amounts should not automatically be framed as more effective or more desirable. The appropriate discussion depends on:

• the reason someone is considering treatment;
• medical history;
• current medications;
• previous NAD+ exposure;
• symptoms;
• and clinician assessment.

Drip Lounge currently offers different NAD+ IV options, but the existence of multiple options should not be interpreted as an instruction to select the highest amount. Treatment decisions should be discussed in the appropriate clinical context.

Common NAD+ IV Therapy Side Effects

Nausea

Nausea is one of the more frequently described infusion-related symptoms in published NAD+ IV reports. In the 2026 pilot, nausea occurred alongside other gastrointestinal symptoms in the small NAD+ group.

If you become nauseated during an infusion, tell the clinician immediately rather than waiting for it to become severe. The treatment may need to be reassessed. Nausea should not be presented as evidence that NAD+ is “working.”

Abdominal Cramping and Stomach Discomfort

Abdominal cramping has also been described during NAD+ IV administration. Possible experiences may include:

• stomach tightening;
• abdominal discomfort;
• cramping;
• gastrointestinal urgency;
• diarrhea;
• or nausea.

Published evidence remains limited, but the 2026 observational study found substantial gastrointestinal discomfort among NAD+ recipients. Persistent or severe abdominal pain deserves clinical evaluation rather than being automatically attributed to the infusion.

Can NAD+ IV Cause Diarrhea or Vomiting?

Both diarrhea and vomiting were reported in the small 2026 NAD+ IV pilot. Again, the study population was too small to estimate how commonly these symptoms occur across the general population.

But these symptoms matter because repeated vomiting or significant diarrhea can contribute to:

• dehydration;
• weakness;
• dizziness;
• electrolyte disturbances;
• and worsening underlying health problems.

Tell your clinician promptly if these symptoms occur. Severe or repeated vomiting, severe abdominal pain, fainting, or inability to maintain fluids can require more urgent evaluation.

Flushing, Warmth, and Sweating

Some people describe warmth, flushing, sweating, or feeling temporarily overheated during IV therapy. These sensations can have multiple possible explanations and should not automatically be attributed to NAD+ itself.

If they occur during treatment, let the clinical team know. Any reaction that is rapidly worsening, accompanied by breathing problems, swelling, faintness, hives, or another concerning symptom requires more urgent assessment.

Headache and Lightheadedness

Headache and lightheadedness may occur during or following IV treatment. Potential contributors can include:

• hydration status;
• food intake;
• stress;
• blood-pressure changes;
• medications;
• an underlying medical condition;
• anxiety;
• or the infusion itself.

A 2024 systematic review of NAD-related interventions reported headaches and fatigue among adverse events, but this evidence should be interpreted carefully: the included randomized trials primarily investigated oral NADH or NAD precursors rather than NAD+ IV therapy. It therefore provides useful background but cannot establish the adverse-event rate for intravenous NAD+.

Persistent, severe, or unusual headache or dizziness should be discussed with a clinician.

Can NAD+ IV Make You Tired?

Yes, some people report temporary fatigue during or after NAD-related treatment. This can sound surprising because NAD+ is frequently marketed around “energy.”

But feeling tired afterward does not automatically mean:

• the infusion was effective;
• your body is “detoxing”;
• your mitochondria are “recharging”;
• or the treatment is producing a positive biological response.

Fatigue has many possible causes, including poor sleep, illness, dehydration, inadequate food intake, stress, medication effects, underlying medical conditions, or the treatment experience itself.

The FDA has also received adverse-event reports following compounded injectable NAD+ products that included fatigue, severe chills, shaking, and vomiting. In that context, FDA expressed concern that inappropriate food-grade ingredients used in sterile compounding may have introduced excessive endotoxins.

That means fatigue following an infusion should not automatically be dismissed. If your main interest is non-IV NAD+, our guide to NAD+ injection effects and timelines explains how experiences with injections may differ from IV treatment.

Chest Pressure, Throat Discomfort, and Increased Heart Rate

These symptoms deserve particular attention. The 2026 NAD+ IV pilot reported chest pressure, throat discomfort, increased heart rate, and congestion among participants during infusion.

Chest pressure or throat discomfort should never simply be normalized as something you need to “push through.” Tell the clinician immediately. Depending on the situation, treatment may need to be stopped, paused, slowed, or followed by additional medical evaluation.

Seek urgent medical care for severe chest pain, difficulty breathing, fainting, severe throat swelling, or persistent/rapidly worsening cardiovascular symptoms.

Are NAD+ IV Side Effects Caused by the NAD+ Itself?

Not necessarily. This is an important safety distinction.

A reaction following an IV infusion can potentially relate to several factors:

• the active ingredient;
• infusion rate;
• concentration;
• another ingredient in the preparation;
• contamination;
• endotoxins;
• IV placement;
• individual medical conditions;
• concurrent medications;
• or another unrelated issue.

FDA has specifically warned compounders about using food-grade NAD+ ingredients to manufacture sterile injectable products. The agency reported receiving adverse-event reports involving injectable NAD+ products, including severe chills, shaking, vomiting, and fatigue, with some patients needing medical treatment. FDA said the reactions were consistent with excessive endotoxin exposure.

In a separate 2026 warning letter, FDA described a compounded NAD+ lot associated with patients developing low blood pressure, uncontrollable shaking, chills, and body aches. Testing found very high bacterial endotoxin levels in an unopened vial from the same lot.

This is why product sourcing and sterile-compounding quality are part of the safety conversation, not just the dose or infusion speed.

What Does NAD+ IV Feel Like?

There is no universal NAD+ IV experience. Some clients may report little or no discomfort. Others may notice temporary sensations during the infusion.

A significant point for marketing NAD+ is that not everyone leaves feeling instantly energized. Immediate energy, focus, euphoria, or mental clarity should not be promised.

How Long Do NAD+ IV Side Effects Last?

There is not enough evidence to give one reliable duration for all NAD+ IV side effects.

In the small 2026 pilot study, infusion-related symptoms resolved when the infusion was completed. That does not mean every reaction will resolve immediately.

Duration may differ depending on the symptom, individual tolerance, underlying medical conditions, other medications, hydration, formulation, and the cause of the reaction. Persistent or worsening symptoms should be medically evaluated.

Do not assume that symptoms lasting hours or days are simply part of an expected “NAD detox.”

NAD+ IV vs. NAD+ Injections: Are the Side Effects the Same?

Not necessarily.

IV therapy delivers NAD+ directly into the bloodstream over a period of time. An injection uses a different administration route and exposure pattern. Therefore, you should not assume NAD+ injection side effects equal NAD+ IV side effects.

Route, preparation, concentration, exposure, and clinical context can all affect tolerability. If you're comparing the formats, review our guide to NAD+ injection effects and timing.

Drip Lounge also provides information on its NAD+ Injection Kit for patients for whom that format is clinically appropriate.

NAD+ IV vs. NAD+ Patches

Transdermal products are another format people encounter when researching NAD-related wellness options. A patch and an IV differ significantly in route of administration, absorption, exposure, convenience, supervision, and available evidence.

If you are comparing the two formats, see NAD+ Transdermal Patches vs. IV Infusions. For a broader explanation of the patch format itself, read Introducing NAD+ Transdermal Patches.

Do not assume that a transdermal product provides the same pharmacological exposure or evidence as IV administration simply because both use the name “NAD+.”

What About Oral NAD+ Support?

Oral products are different again. Some products contain NAD-related compounds or precursors intended to support NAD metabolism rather than delivering intravenous NAD+. The evidence cannot automatically be transferred from one route to another.

This distinction is particularly important when reading scientific studies. For example, the 2024 systematic review often cited in NAD marketing primarily evaluated oral NADH and NAD precursors, not standard commercial NAD+ IV protocols.

Drip Lounge's NAD Support Capsules represent a different format and should be evaluated separately from IV treatment.

NAD+ IV vs. Niagen IV

Another option sometimes discussed alongside NAD+ IV is nicotinamide riboside, or NR, including IV formulations. NR is a precursor that the body can use within NAD-related pathways rather than being identical to NAD+ itself.

The 2026 pilot study that directly compared NAD+ IV with NR IV found a notable tolerability difference: the NAD+ group experienced substantially more infusion-related symptoms and took longer to complete treatment. However, it was a very small retrospective pilot. It cannot establish that NR IV is universally safer or preferable.

For a practical comparison, see Niagen IV vs. NAD+ IV.

Who Should Use Extra Caution Before NAD+ IV?

A clinician should review your medical history before treatment. Make sure the clinical team knows if you have concerns involving:

• heart disease;
• heart rhythm;
• blood pressure;
• circulation;
• kidney disease;
• liver disease;
• chronic gastrointestinal disease;
• multiple prescription medications;
• previous serious allergic reactions;
• pregnancy;
• breastfeeding;
• or plans for pregnancy.

You should also discuss unexplained symptoms such as persistent fatigue, unexplained weight loss, recurrent nausea, chest discomfort, shortness of breath, fainting, or new neurological symptoms. These symptoms may require medical evaluation rather than a wellness infusion.

NAD+ IV Should Not Replace Medical Treatment

NAD+ has become heavily marketed online for conditions ranging from aging to addiction and neurological disease. But biological plausibility is not the same as proven clinical treatment.

NAD+ IV should not be presented as an established treatment for:

• Alzheimer's disease;
• Parkinson's disease;
• depression;
• anxiety;
• ADHD;
• addiction;
• chronic fatigue syndrome;
• cancer;
• cardiovascular disease;
• dementia;
• or another diagnosed medical condition

unless and until high-quality evidence and appropriate regulatory approval support the specific claim.

The 2024 systematic review concluded that further high-quality research is necessary to establish clinical benefits across specific conditions. Crucially, much of its evidence involved oral NADH or precursors, not intravenous NAD+.

Is NAD+ IV Proven for Anti-Aging?

No high-quality clinical evidence establishes that NAD+ IV reverses aging or extends human lifespan.

NAD biology is relevant to cellular aging research, which helps explain interest in the field. However, that should not be translated into guarantees that an infusion reverses biological age, repairs aging cells, extends lifespan, prevents dementia, restores youth, or “recharges” mitochondria in a clinically proven way.

Our broader article on NAD therapy, aging, and brain-health research explores these proposed areas with the appropriate evidence context.

When Should You Seek Urgent Medical Care?

Seek urgent medical attention for severe symptoms, including:

• severe chest pain or pressure;
• difficulty breathing;
• fainting or near-fainting;
• facial, lip, tongue, or throat swelling;
• severe or repeated vomiting;
• severe abdominal pain;
• confusion;
• sudden severe weakness;
• new neurological symptoms;
• or a fast or irregular heartbeat that does not settle.

Do not try to manage potentially serious symptoms yourself by speeding or slowing an IV, adding supplements, drinking excessive fluids, taking another medication, or simply waiting because someone online described it as a normal NAD reaction.

How Drip Lounge Approaches NAD+ IV Safety

Health Review Before Treatment

Before an infusion, relevant information may include current health conditions, current medications, allergies, previous IV experiences, current symptoms, and the reason you are considering NAD+. The purpose is to identify issues that may affect whether IV treatment is appropriate.

Individual Tolerance Matters

The infusion experience can vary substantially. If symptoms such as nausea, cramping, headache, flushing, fatigue, chest discomfort, or another unusual sensation occur, tell the clinical team immediately. You should not feel pressure to “tough it out” to finish an infusion.

Treatment Can Be Reassessed

Depending on the symptoms and clinical situation, a clinician may determine that the infusion needs to be slowed, paused, discontinued, or followed by further medical evaluation.

Higher Is Not Automatically Better

Drip Lounge offers several NAD+ IV options. The existence of higher-dose options should never be interpreted to mean that the highest option is inherently more effective or suitable. A clinician-guided discussion should come first.

NAD+ Product Quality Is Part of Safety

IV products bypass many of the body's natural barriers. Sterility and ingredient quality therefore matter substantially.

FDA has warned that food-grade NAD+ ingredients are not appropriate for sterile drug compounding without appropriate processing, because contamination with microorganisms or endotoxins can harm patients. FDA also took enforcement action in 2026 against a compounding facility that had produced NAD+ injectable products under conditions that did not meet the applicable requirements for outsourcing-facility exemptions.

For patients, this reinforces several useful questions:

• Where does the medication come from?
• Who prepared it?
• Is it intended for sterile pharmaceutical compounding?
• How is quality controlled?
• Is the clinic using an appropriate licensed pharmacy pathway?

A dramatically cheaper IV is not necessarily a better value if product quality cannot be verified.

What Research Still Does Not Tell Us

This is arguably the most important section of the article.

Human evidence specifically evaluating commercial intravenous NAD+ therapy remains limited. The recent 2026 pilot contributes useful information about tolerability, but it was retrospective, very small, short-term, conducted in a real-world wellness setting, and not designed to establish broad clinical efficacy.

Current evidence does not establish that NAD+ IV:

• prevents disease;
• reverses aging;
• treats dementia;
• cures fatigue;
• repairs DNA in a clinically meaningful patient outcome;
• treats addiction;
• improves depression;
• produces guaranteed cognitive enhancement;
• or extends lifespan.

Long-term questions also remain around repeated exposure, optimal dosing, ideal treatment frequency, comparative effectiveness, patient selection, and the relationship between measurable NAD-related biomarkers and meaningful health outcomes.

That is why marketing claims should remain much more cautious than the underlying cellular science might initially suggest.

Frequently Asked Questions

Is NAD+ IV Therapy Safe?

NAD+ IV may be tolerated by some people under clinical supervision, but a comprehensive long-term safety profile for commercial NAD+ IV wellness use is not established. Published reports describe gastrointestinal discomfort, chest pressure, increased heart rate, and other infusion-related symptoms, and FDA has separately warned about quality problems involving some compounded injectable NAD+ products.

What Are the Most Common NAD+ IV Side Effects?

Reported infusion-related experiences include nausea, abdominal cramping, diarrhea, vomiting, throat discomfort, chest pressure, and increased heart rate. The evidence base is still too small to reliably estimate how frequently each symptom occurs in the wider population.

Why Does NAD+ IV Cause Nausea or Cramping?

Published clinical observations suggest infusion tolerance may be related to administration pace, but the exact mechanism behind every symptom is not fully established. Tell your clinician immediately if nausea or cramping occurs.

Can NAD+ IV Make You Tired?

Yes, temporary fatigue has been reported following NAD-related treatments, but fatigue has many possible causes. It should not automatically be interpreted as proof that treatment is working.

Can NAD+ IV Cause Chest Pressure?

Chest pressure has been described in published NAD+ IV observations. Report any chest discomfort immediately. Severe pain, breathing difficulty, fainting, or persistent cardiovascular symptoms require urgent medical evaluation.

Can NAD+ IV Increase Heart Rate?

Increased heart rate was reported among participants receiving NAD+ in the 2026 pilot study. Because cardiovascular symptoms can have many causes, palpitations or a racing heartbeat during an infusion should be reported promptly.

How Long Do NAD+ IV Side Effects Last?

There is no universal duration. In one small 2026 pilot, infusion-related symptoms resolved following completion of the infusion, but that does not establish what will happen for every patient. Persistent or worsening symptoms require medical assessment.

Does Everyone Feel Energized After NAD+ IV?

No. Some people may report subjective energy or focus changes, others may feel tired, and others may notice no immediate effect. Immediate energy should not be guaranteed.

Is NAD+ IV FDA-Approved?

There is no FDA-approved NAD+ IV drug indicated to prevent aging or broadly treat the health conditions frequently associated with wellness marketing. Compounded injectable NAD+ products also do not undergo the same FDA premarket approval process as approved drug products. FDA has raised specific safety concerns about the quality of ingredients used in some sterile NAD+ compounding.

Is NAD+ IV Better Than NAD+ Injections or Patches?

There is not enough high-quality comparative evidence to declare one NAD-related delivery format universally “better.” Route, goals, evidence, convenience, supervision, and individual circumstances differ. For more context, compare NAD+ patches vs. IV infusions and NAD+ injection effects.

Related NAD+ Education

Sources Reviewed

This article uses current evidence relevant to NAD safety and IV administration:

• Frontiers in Aging, 2026: Small retrospective pilot directly comparing intravenous NAD+ with intravenous nicotinamide riboside. NAD+ recipients experienced substantially more infusion-related gastrointestinal and cardiovascular symptoms.
• PMC version of the 2026 pilot: Detailed tolerability results and infusion durations.
• American Journal of Physiology, 2024: Systematic review of human NAD-related interventions. Useful for broader safety context, but primarily based on oral NADH/NAD precursor interventions rather than NAD+ IV.
• U.S. FDA: Warning regarding use of food-grade NAD+ ingredients in sterile compounding and reports of severe chills, shaking, vomiting, and fatigue following injectable NAD+ products.
• U.S. FDA, January 2026: Warning letter describing an NAD+ compounded product associated with adverse reactions and excessive bacterial endotoxin.

Recommended medical review cadence: Every 6 months, or sooner if FDA guidance, injectable NAD+ compounding policy, or meaningful clinical evidence changes.

The Bottom Line on NAD+ IV Therapy Side Effects

NAD+ plays an essential role in normal human cellular biology. That does not mean intravenous NAD+ is automatically risk-free or that every wellness claim surrounding it has been clinically proven.

Current evidence shows that NAD+ IV can produce meaningful infusion-related discomfort in some people, including nausea, abdominal cramping, diarrhea, vomiting, throat discomfort, chest pressure, and increased heart rate.

FDA has also identified a separate safety concern: sterile-compounding quality. The agency has received adverse-event reports following injectable NAD+ and has warned against inappropriate use of food-grade NAD+ ingredients in sterile injectable products.

For someone considering treatment, the most useful question is therefore not simply “Does NAD+ IV have side effects?” It is: “Is this appropriate for me, is the product coming through an appropriate clinical pathway, and how will the team respond if I do not tolerate the infusion comfortably?”

At Drip Lounge, NAD+ IV should be approached through clinician review, individualized treatment decisions, ongoing communication during the infusion, and realistic expectations about what current evidence can—and cannot—promise.

Considering Your First NAD+ IV?

Review the NAD+ IV treatment options and discuss your medical history, medications, goals, and safety questions with the clinical team before treatment.